# Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/clostridioides-difficile-infection-developing-drugs-for-treatment-reduction-of-recurrence-and-prevention/b0e5f4fd-4c99-48d2-ad08-77dfb3fc2cc2

> FDA guidance document: Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention. Issue date: October 27, 2022. Get complete insights and analysis.

---

## Details

- Title: Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-10-27
- Comment Close Date: 2022-12-27
- Last Changed: 2022-10-31
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-1261">FDA-2022-D-1261</a>

## Related Documents

- [Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/chronic-hepatitis-d-virus-infection-developing-drugs-for-treatment-guidance-for-industry/a162cb79-9621-497d-a34f-dd8e97dfa9b3)
- [Pulmonary Tuberculosis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/pulmonary-tuberculosis-developing-drugs-for-treatment/8b46de55-ddca-4887-a2ad-5d46be5633aa)
- [Postoperative Nausea and Vomiting: Developing Drugs for Prevention](https://www.globalkeysolutions.net/guidances/guidance-document/postoperative-nausea-and-vomiting-developing-drugs-for-prevention/d423e99c-8d8f-4f7a-bb91-694c270c2ba3)